Publications by authors named "Lara-Medrano R"
Background: COVID-19 may trigger an acute hyperinflammatory syndrome characterised by heightened levels of acute phase reactants and is associated with adverse outcomes among hospitalised individuals. The relationship between 48-hour changes in acute phase reactants and adverse outcomes is unclear. This study evaluated the relationship between change in four acute phase reactants (interleukin-6, procalcitonin, ferritin, and C-reactive protein), and the risk for in-hospital death and invasive mechanical ventilation.
View Article and Find Full Text PDFObjectives: To evaluate the effect of azithromycin (AZM) on biofilm formation and composition in multidrug resistant (MDR) Acinetobacter baumannii.
Material And Methods: Ninety-six A. baumannii isolates were studied.
Background: High flow oxygen therapy (HFO) is a widely used intervention for pulmonary complications. Amid the coronavirus infectious disease 2019 (COVID-19) pandemic, HFO became a popular alternative to conventional oxygen supplementation therapies. Risk stratification tools have been repurposed -and new ones developed- to estimate outcome risks among COVID-19 patients.
View Article and Find Full Text PDFAim: To develop a CT predictor scale for the need for colectomy and to evaluate predictors of all-cause mortality within 30 days after diagnosis of infection (CDI).
Methods: We conducted a retrospective study of adult hospitalized patients whounderwent abdominal CT within 72 h of diagnosis of CDI.
Results: Presence of abnormal wall thickening in caecum (OR 8.
Article Synopsis
- Mucormycosis is a severe fungal infection, with rhinocerebral cases being the most common, often difficult to diagnose if chronic.
- A 47-year-old diabetic man presented with swelling linked to chronic mucormycosis, confirmed by biopsy which showed specific fungal hyphae, and was effectively treated with surgery and antifungal medication.
- A historical review from 1964-2014 identified 22 cases, highlighting that both immunocompetent and immunocompromised individuals can be affected; treatment mainly revolves around surgery and antifungals, with regular follow-up needed due to potential recurrence.
A human parvovirus B19 outbreak was detected in personnel assigned to a surgical area (anesthesiology fellows and an otorhinolaryngology fellow) in a university hospital. The attack rate between susceptible members was higher than previous reports. Diagnosis was determined by polymerase chain reaction for human parvovirus B19 in serum of 1 subject and immunoglobulin M/immunoglobulin G antibody titer in the remaining subjects.
View Article and Find Full Text PDF